ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

May 30, 2014

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

ACS Adopts ‘Measures of Success’ To Mark Progress T0 Yr. 2000

April 17, 1992

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

P01 Reviewers Asked To Look Closely At Number Of Projects

October 2, 1992

NIH Seeks Method For Allocating Research Funds, Determine Economic Impact By Disease Category

April 26, 1974